impetus Archives -

Trust in life science companies has fluctuated since the start of the pandemic. The reputation of COVID-19 vaccine

Transparency, social change can help pharma regain the public’s trust

https://pharmaphorum.com/patients/transparency-social-change-can-help-pharma-regain-the-publics-trust/

“Diversity.” It’s a word that is very commonly thrown around right now, not just in pharma and healthcare

Importance of diversity in pharma and clinical trials

https://pharmaphorum.com/r-d/importance-diversity-pharma-and-clinical-trials-impetus/

Pharmaceutical companies are traditionally more conservative with their approach to and incorporation of new technologies; however, prior to

Refining digital collaboration

https://pharmaphorum.com/sales-marketing/refining-digital-collaboration/

As the world passes the year and a half mark of the COVID-19 pandemic, the evolving ‘new normal’

Virtual engagement and collaborations: the pharmaphorum podcast

https://pharmaphorum.com/digital/virtual-engagement-impetus-digital/

Pharma has been forced to hold its meetings virtually for most of the year now – but despite

Virtual meetings: Where are we now and where are we going?

https://pharmaphorum.com/views-analysis-digital/virtual-meetings-where-are-we-now-and-where-are-we-going/

COVID-19 might have forced pharma to finally fully embrace digital comms, but it’s been a steep learning curve

Deep Dive: Communications 2020

https://pharmaphorum.com/sales-marketing/deep-dive-communications-2020/

If pharma wants to be truly patient-centric, it needs to be talking to patients. This may seem obvious,

Getting patients round the virtual table

https://pharmaphorum.com/views-analysis-oncology/impetus-digital-patient-centric-engagement/

Barely a day goes by without global warming or climate change (now more appropriately termed “climate crisis” by

Why pharma needs to care about global warming

https://pharmaphorum.com/views-and-analysis/why-pharma-needs-to-care-about-global-warming/

impetus